bioAffinity Technologies, Inc. (BIAF)
9.93
-0.57
(-5.43%)
USD |
NASDAQ |
Sep 10, 13:28
bioAffinity Technologies Shareholders Equity (Quarterly) : 3.769M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.769M |
| March 31, 2026 | 3.661M |
| December 31, 2025 | 7.278M |
| September 30, 2025 | 8.902M |
| June 30, 2025 | -2.136M |
| March 31, 2025 | 1.439M |
| December 31, 2024 | 2.602M |
| September 30, 2024 | 3.121M |
| June 30, 2024 | 3.433M |
| March 31, 2024 | 5.257M |
| December 31, 2023 | 4.855M |
| September 30, 2023 | 6.994M |
| Date | Value |
|---|---|
| June 30, 2023 | 8.098M |
| March 31, 2023 | 9.668M |
| December 31, 2022 | 11.04M |
| September 30, 2022 | 12.60M |
| June 30, 2022 | -12.74M |
| March 31, 2022 | -12.68M |
| December 31, 2021 | -11.75M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -11.03M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 137.28M |
| Perspective Therapeutics, Inc. | 323.86M |
| MiMedx Group, Inc. | 216.00M |
| Veracyte, Inc. | 1.388B |
| ABVC BioPharma, Inc. | 10.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.619M |
| Total Liabilities (Quarterly) | 3.850M |
| Debt to Equity Ratio | 0.3808 |
| Current Ratio | 1.442 |
| Net Debt Paydown Yield | -0.38% |